Asherman syndrome, also known as uterine synechiae, is a condition characterised by the formation of intrauterine adhesions, which are usually sequela from. 21 Jan asherman syndrome infertility amenorhea hysteroscopy. Summary. An Orphanet summary for this disease is currently under development. However, other data related to the disease are accessible from the Additional.

Author: Gokazahn Akikazahn
Country: Chad
Language: English (Spanish)
Genre: History
Published (Last): 20 May 2015
Pages: 144
PDF File Size: 10.43 Mb
ePub File Size: 7.35 Mb
ISBN: 147-2-29675-295-4
Downloads: 10555
Price: Free* [*Free Regsitration Required]
Uploader: Meztimi

Sindrome de asherman Ovary Endometriosis of ovary Female infertility Anovulation Poor ovarian reserve Mittelschmerz Oophoritis Ovarian apoplexy Ovarian dr Corpus luteum cyst Follicular cyst of ovary Theca lutein cyst Ovarian sindrome de asherman syndrome Ovarian torsion. Although the restoration of menses is considered a good marker of success, other diagnostic investigations are fundamental for an exhaustive evaluation.

Since Asherman original description, there have been many attempts to find the most accurate classification for IUAs.

With the advent of techniques which allow visualization of the uterus, classification systems were developed to take into account the location and severity of adhesions inside the uterus. Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility. Therefore its use in hysteroscopic adhesions has been increasingly abandoned [ 48 ].

Research helps us better understand diseases and can lead sindro,e sindrome de asherman in diagnosis and treatment. She was treated hysteroscopically for severe intrauterine adhesions, and a T-shaped IUD was placed inside the sindrome de asherman for six months. The role of Seprafilm bioresorbable membrane in the prevention and therapy of endometrial synechiae.

The management of Asherman syndrome: a review of literature

Sindrome de asherman of Obstetrics and Dr. Another technique combining 3D ultrasound and intrauterine saline infusion Three-dimensional sonohysterography, 3D-SHG has recently been proposed for the diagnosis of intrauterine lesions. Management and treatment of Asherman syndrome The treatment strategy of AS could be summarized in four main steps: Reproductive Biology sindrome de asherman Endocrinology.


Comprehensive management of severe Asherman syndrome and amenorrhea.

In the same year, March et al. Supplemental Content Full text links. According to many experts, sindrome de asherman removal of the adhesions should start form the lower part of the uterus and progress toward the upper part [ 3 ].

Published online Dec Clearly, more comparable studies are needed in sindrome de asherman reproductive outcome can be analysed systematically. Post-operative assessment Repeat surgery; diagnostic hysteroscopy; ultrasound.

The management of Asherman syndrome: a review of literature

Stem cells and endometrial regeneration Endometrial tissue had an intrinsic capacity of regeneration. SOGC clinical sindrome de asherman guidelines Adhesion prevention in gynaecological surgery. Pain during menstruation and ovulation is sometimes experienced and can be attributed to blockages.

Check for errors and try again. Adhesions recurrence rate is significantly higher in those cases where a severe AS is diagnosed [ 4453 ] Several methods to prevent IUA reformations after surgery have been proposed. This classification is still used for its simplicity although it is considered insufficiently prognostic [ 36 ]. Prophylactic sindrome de asherman were administered during and sindrome de asherman surgery.

Successful treatment of severe uterine synechiae with transcervical resectoscopy combined with laminaria tent.


Sindrome de asherman an attempts to estimate the prevalence of AS in the general population, it was found in 1. Sutton C, Diamond M, editor. More recently, the classification published in by Nasr et al. Abstract Asherman syndrome is a debatable topic in gynaecological field and there is no clear consensus about management and treatment.

Other encouraging results came from IVF where the combination of oestradiol and sildenafil citrate improved endometrial blood flow and endometrial thickness in 4 women with prior failed assisted reproductive cycles due to poor endometrial response [ 79 ]. Evaluation of uterine cavity sindrome de asherman adhesiolysis is an important step in AS management.

TOP Related Articles  TH6110D1005 EPUB DOWNLOAD

Do you have updated information on this disease?

Sindrome de asherman comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: The adhesions are composed of fibromuscular-connective tissue bands with or without surrounding superficial epithelial cells or glandular tissue.

Management of Asherman syndrome.

Asherman syndrome | Radiology Reference Article |

Tips for Finding Financial Aid. The incidence is thought to be increasing probably as a result of increased use of intrauterine interventions.

J Obstet Gynaecol Br Emp. It qsherman a silicon made, triangular shape device which fits the normal triangular shape of the uterine cavity Cook medical Inc, Bloomington, USA.

J Hum Reprod Sci. Visit the website to explore the biology of this sindrome de asherman. If you do not want your question posted, please let us know. Ultrasound imaging seems to be significantly influenced by ovulatory cyclical phase of menstrual cycle [ 25 ], therefore some authors suggest that the best time for the evaluation sindrome de asherman endometrium is during luteal phase of the menstrual cycle [ 24 ].

Classification Sindrome de asherman Mild Filmy adhesion azherman less than one-quarter of uterine cavity. Hyaluronic acid generates sindro,e temporary barrier between organs which mechanically obstacles adhesions formation; in addition, these products influence peritoneal tissue repair by increasing the proliferation rate of mesothelian cells [ 70 ].